The apolipoprotein E epsilon 4 allele causes a faster decline of cognitive performances in Down's syndrome subjects

被引:62
作者
DelBo, R [1 ]
Comi, GP [1 ]
Bresolin, N [1 ]
Castelli, E [1 ]
Conti, E [1 ]
Degiuli, A [1 ]
Ausenda, CD [1 ]
Scarlato, G [1 ]
机构
[1] UNIV MILAN,IST CLIN NEUROL,CTR DINO FERRARI,IRCCS OSPED MAGGIORE POLICLIN,I-20122 MILAN,ITALY
关键词
apolipoprotein E4; Down's syndrome; Alzheimer's disease; mental retardation; cognitive ability; amyloid;
D O I
10.1016/S0022-510X(96)00249-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The apolipoprotein E gene (APOE), located on human chromosome 19, has three common alleles (epsilon 2, epsilon 3, epsilon 4) which encode for the three main isoforms indicated as E2, E3 and E4 respectively. Several findings indicate epsilon 4 allele as an importan risk factor in both sporadic and familial late-onset Alzheimer's disease (AD). Pathological changes similar to AD are seen in almost all patients with Down's syndrome (DS) aged over 35 (senile plaques, neurofibrillary tangles and neuronal loss); a proportion of these may subsequently develop dementia. Aim of this study is to evaluate the possible pathological role of epsilon 4 allele as risk factor for developing AD in a DS population. ApoE epsilon 4 allele frequency is not significantly different in DS cases and controls. We found a statistically significant inverse correlation between full scale IQ values and age of patients in the subgroup of DS subjects selected for the presence of at least one epsilon 4 allele, while no correlation was observed in DS subjects with other ApoE genotypes. A longitudinal analysis of cognitive performances (available in 38 patients) showed a faster rate of decline in intellectual ability in those subjects carrying at least one epsilon 4 allele. Our data support the hypothesis that ApoE epsilon 4 allele has a contributory role in accelerating the mental deterioration of AD-type in DS patients. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:87 / 91
页数:5
相关论文
共 25 条
  • [1] BECKER LE, 1993, APMIS, V101, P57
  • [2] CLINICAL RELEVANCE OF THE QUANTIFICATION OF APOLIPOPROTEIN-E IN CEREBROSPINAL-FLUID
    CARLSSON, J
    ARMSTRONG, VW
    REIBER, H
    FELGENHAUER, K
    SEIDEL, D
    [J]. CLINICA CHIMICA ACTA, 1991, 196 (2-3) : 167 - 176
  • [3] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
    CORDER, EH
    SAUNDERS, AM
    STRITTMATTER, WJ
    SCHMECHEL, DE
    GASKELL, PC
    SMALL, GW
    ROSES, AD
    HAINES, JL
    PERICAKVANCE, MA
    [J]. SCIENCE, 1993, 261 (5123) : 921 - 923
  • [4] DOWNS-SYNDROME, DEMENTIA, AND SUPEROXIDE-DISMUTASE
    DICKINSON, MJ
    SINGH, I
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1993, 162 : 811 - 817
  • [5] APOLIPOPROTEIN-E IS LOCALIZED TO THE CYTOPLASM OF HUMAN CORTICAL-NEURONS - A LIGHT AND ELECTRON-MICROSCOPIC STUDY
    HAN, SH
    EINSTEIN, G
    WEISGRABER, KH
    STRITTMATTER, WJ
    SAUNDERS, AM
    PERICAKVANCE, M
    ROSES, AD
    SCHMECHEL, DE
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1994, 53 (05) : 535 - 544
  • [6] HIXSON JE, 1990, J LIPID RES
  • [7] AGE-RELATED DISTRIBUTION OF NEUROPATHOLOGIC CHANGES IN THE CEREBRAL-CORTEX OF PATIENTS WITH DOWNS-SYNDROME - QUANTITATIVE REGIONAL-ANALYSIS AND COMPARISON WITH ALZHEIMERS-DISEASE
    HOF, PR
    BOURAS, C
    PERL, DP
    SPARKS, DL
    MEHTA, N
    MORRISON, JH
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (04) : 379 - 391
  • [8] DOWNS-SYNDROME AND THE LINKS WITH ALZHEIMERS-DISEASE
    HOLLAND, AJ
    OLIVER, C
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (02) : 111 - 114
  • [9] NEUROPATHOLOGICAL CHANGES IN DOWNS-SYNDROME HIPPOCAMPAL-FORMATION - EFFECT OF AGE AND APOLIPOPROTEIN-E GENOTYPE
    HYMAN, BT
    WEST, HL
    REBECK, GW
    LAI, F
    MANN, DMA
    [J]. ARCHIVES OF NEUROLOGY, 1995, 52 (04) : 373 - 378
  • [10] MANN DMA, 1992, NEURODEGENERATION, V1, P201